# FDA Inspection 1099074 - Octapharma Plasma, Inc. - July 03, 2019

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/110b8524-a58d-417a-abee-70e2a2fcc2bb
Source feed: FDA_Inspections

> FDA Inspection 1099074 for Octapharma Plasma, Inc. on July 03, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1099074
- Company Name: Octapharma Plasma, Inc.
- Inspection Date: 2019-07-03
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1292178 - 2025-11-06](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/2b48cdad-1ce5-4e59-8e94-7fb3b3920109)
- [FDA Inspection 1292178 - 2025-11-06](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/939c4435-c9e0-4eaa-8dcf-d452dd5f73c9)
- [FDA Inspection 1215163 - 2023-07-21](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/69b306d5-be70-4c6d-af39-9b9c5a6d43da)
- [FDA Inspection 1083437 - 2019-03-01](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/3068b1e1-b9c8-4493-b82d-af25e889bf1f)
- [FDA Inspection 633306 - 2009-12-03](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/2004491a-3045-4814-9956-4965b26740d6)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/cb18ee98-c6ed-436f-a6c4-bdd0e525a8a1

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d